CONMED
CNMD
227 hedge funds and large institutions have $2.13B invested in CONMED in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 37 closing their positions.
26% more call options, than puts
Call options by funds: $6.3M | Put options by funds: $4.98M
25% more capital invested
Capital invested by funds: $1.71B → $2.13B (+$421M)
0% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 79
1% less funds holding
Funds holding: 229 → 227 (-2)
3% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 37
1.13% less ownership
Funds ownership: 104.88% → 103.75% (-1.1%)
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$46.3M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$45M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$44.3M |
| 4 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
+$22.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.5M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$60.2M |
| 2 |
HM
HealthCor Management
New York
|
-$39.4M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$34.2M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$26.9M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$17.9M |
CNMD Hedge Fund Activity: Q2 2020 in Review
227 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2020, worth a combined $2.13B — up 25% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of CNMD and 36 opened new positions — a net loss of 1 holder — while 79 trimmed existing stakes and 79 added.
The largest buyer was Point72 Asset Management, adding an estimated $46.3M. The largest seller was Capital Research Global Investors, cutting an estimated $60.2M.
- 227 institutional investors held CONMED (CNMD) as of Q2 2020, down from 229 in Q1 2020.
- Funds reported $2.13B of CONMED stock for Q2 2020, up 25% quarter-over-quarter.
- 36 funds opened new CONMED positions in Q2 2020 and 37 closed out, a net change of -1 holder.
- The largest CONMED buyer in Q2 2020 was Point72 Asset Management, an estimated $46.3M added.
- The largest CONMED seller in Q2 2020 was Capital Research Global Investors, an estimated $60.2M sold.
Based on aggregated 13F filings for Q2 2020.